Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2021 | Aging and Renal Disease: Old Questions for New Challenges | YU-HSIANG CHOU ; Chen, Yung-Ming | Aging and disease | | | |
2021 | Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients | Chiu, Yen-Ling; Lin, Wei-Chou; Shu, Kai-Hsiang; Fang, Yi-Wen; Chang, Fan-Chi; Chou, Yu-Hsiang ; Wu, Ching-Fang; Chiang, Wen-Chih; Lin, Shuei-Liong; Chen, Yung-Ming; Wu, Ming-Shiou | Frontiers in immunology | | | |
2014 | Angiopoietin-2-induced arterial stiffness in CKD | Chang F.-C.; Chiang W.-C.; Tsai M.-H.; YU-HSIANG CHOU ; Pan S.-Y.; Chang Y.-T.; Yeh P.-Y.; Chen Y.-T.; Chiang C.-K.; Chen Y.-M.; Chu T.-S.; Wu K.-D.; Lin S.-L. | Journal of the American Society of Nephrology | | | |
2019 | Associations between preoperative continuation of renin–angiotensin system inhibitor and cardiac surgery-associated acute kidney injury: a propensity score-matching analysis | YU-HSIANG CHOU ; Huang T.-M.; Wu V.-C.; Chen W.-S.; Wang C.-H.; Chou N.-K.; Chiang W.-C.; Chu T.-S.; Lin S.-L.; National Taiwan University Study Group on Acute Renal Failure (NSARF) | Journal of Nephrology | | | |
2011 | Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis | Liao C.-T.; Kao T.-W.; YU-HSIANG CHOU ; Wu M.-S.; Chen Y.-M.; Chuang H.-F.; Hung K.-Y.; Chu T.-S.; Wu K.-D.; Tsai T.-J. | Nephrology Dialysis Transplantation | | | |
2021 | AST-120 Improves Cardiac Dysfunction in Acute Kidney Injury Mice via Suppression of Apoptosis and Proinflammatory NF-κB/ICAM-1 Signaling | Shen, Wen-Ching; YU-HSIANG CHOU ; Shi, Li-Shian; Chen, Zhi-Wei; Tu, Hai-Jian; Lin, Xin-Yi; Wang, Guei-Jane | Journal of inflammation research | | | |
2016 | Autonomic dysfunction in chronic kidney disease: An old problem in a new era | YU-HSIANG CHOU ; Tsai T.-J. | Journal of the Formosan Medical Association | | | |
2012 | Clinical outcomes and predictors for ESRD and mortality in primary GN | YU-HSIANG CHOU ; Lien Y.-C.; Hu F.-C.; Lin W.-C.; Kao C.-C.; Lai C.-F.; Chiang W.-C.; Lin S.-L.; Tsai T.-J.; Wu K.-D.; Chen Y.-M. | Clinical Journal of the American Society of Nephrology | | | |
2019 | Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis | YU-HSIANG CHOU ; Lin W.-C.; Chen Y.-M. | Diabetes Research and Clinical Practice | | | |
2021 | Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study | Lin, Shu-Yung; Feng, Jia-Yih; Lee, Chih-Yuan; Lin, Yi-Chih; YU-HSIANG CHOU ; Lin, Kuan-Yin; Wei, Yu-Feng; Lin, Shu-Wen; Chang, Chin-Hao; Wang, Ping-Huai; Shu, Chin-Chung; Wang, Jann-Yuan; Yu, Chong-Jen | Antimicrobial agents and chemotherapy | | | |
2010 | Disseminated Mycobacterium kansasii infection associated with hemophagocytic syndrome | YU-HSIANG CHOU ; Hsu M.-S.; Sheng W.-H.; Chang S.-C. | International Journal of Infectious Diseases | | | |
2016 | DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys | Chang Y.-T.; Yang C.-C.; Pan S.-Y.; YU-HSIANG CHOU ; Chang F.-C.; Lai C.-F.; Tsai M.-H.; Hsu H.-L.; Lin C.-H.; Chiang W.-C.; Wu M.-S.; Chu T.-S.; Chen Y.-M.; Lin S.-L. | Journal of Clinical Investigation | | | |
2017 | Early initiation of immunosuppressive treatment in membranous nephropathy patients | Chan C.K.; Lai T.S.; Chen P.M.; YU-HSIANG CHOU ; Wu C.F.; Chiu Y.L.; Chiang W.C.; Chen Y.M.; Chu T.-S.; Wu K.D. | Journal of the Formosan Medical Association | | | |
2020 | Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis | Lin Y.-C.; Lai T.-S.; Wu H.-Y.; YU-HSIANG CHOU ; Chiang W.-C.; Lin S.-L.; Chen Y.-M.; Chu T.-S.; Tu Y.-K. | Clinical Pharmacology and Therapeutics | | | |
2010 | Emphysematous colitis of ascending colon with portal venous air caused by diffuse large B-cell lymphoma | YU-HSIANG CHOU ; Hsu H.-L.; Lee J.-C.; Lin B.-R.; Liu K.-L. | Journal of Clinical Oncology | | | |
2016 | Enthusiasm for induced pluripotent stem cell-based therapies in kidney regeneration | Shen W.-C.; YU-HSIANG CHOU ; Lin S.-L. | Journal of the Formosan Medical Association | | | |
2019 | Erythropoietin modulates macrophages but not post-ischemic acute kidney injury in mice | YU-HSIANG CHOU ; Liao F.-L.; Chen Y.-T.; Yeh P.-Y.; Liu C.-H.; Shih H.-M.; Chang F.-C.; Chiang W.-C.; Chu T.-S.; Lin S.-L. | Journal of the Formosan Medical Association | | | |
2019 | Heart rate variability as a predictor of rapid renal function deterioration in chronic kidney disease patients | YU-HSIANG CHOU ; Huang W.-L.; Chang C.-H.; Yang C.C.H.; Kuo T.B.J.; Lin S.-L.; Chiang W.-C.; Chu T.-S. | Nephrology | | | |
2013 | How to confirm the specific effect of spironolactone in chronic kidney disease caused by ischemic acute kidney injury? | YU-HSIANG CHOU ; Lin S.-L. | Kidney International | | | |
2011 | Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury | YU-HSIANG CHOU ; Huang T.-M.; Wu V.-C.; Wang C.-Y.; Shiao C.-C.; Lai C.-F.; Tsai H.-B.; Chao C.-T.; Young G.-H.; Wang W.-J.; Kao T.-W.; Lin S.-L.; Han Y.-Y.; Chou A.; Lin T.-H.; Yang Y.-W.; Chen Y.-M.; Tsai P.-R.; Lin Y.-F.; Huang J.-W.; Chiang W.-C.; Chou N.-K.; Ko W.-J.; Wu K.-D.; Tsai T.-J. | Critical Care | | | |